NCT06593899View on ClinicalTrials.gov

The Total Neoadjuvant Therapy for Soft Tissue Sarcoma of the Extremities

PHASE2RecruitingINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

July 1, 2026

Conditions
Soft Tissue Sarcomas
Interventions
RADIATION

Hypofractionated Radiotherapy

Hypofractionated radiotherapy Preoperative hypofractionated 5x5 Gy radiotherapy (5 consecutive days) prescribed on planned target volume

DRUG

3 cycles of AI

Three courses of doxorubicin and ifosfamide (AI, doxorubicin 75 mg/sqm and ifosfamide 10 g/sqm with prophylactic mesna)

Trial Locations (1)

350001

RECRUITING

Fujian Medical University Union Hospital, Fuzhou

All Listed Sponsors
lead

Fujian Medical University Union Hospital

OTHER